Roche, Basel, Switzerland, has reached an agreement to acquire all shares of Viewics Inc, Sunnyvale, Calif. With the acquisition, Roche aims to expand its position in the integrated core lab with business analytics capabilities, enabling laboratories to make faster data-driven informed decisions about their operations and processes. The Cloud-based system was developed to be secure, infrastructure-agnostic, interactive, and accessible from multiple devices, including desktop computers, smart phones, and tablets.
“We are excited that Viewics Inc will be joining the Roche Group, as it will help us to support our customers around the world in improving their lab performance and processes,” says Roland Diggelmann, CEO of Roche Diagnostics. “The Viewics solution offers our customers insights at their fingertips, uncovering potential value and profitability drivers in lab operations, and indicators to improve overall quality of care.”
“We founded Viewics with the belief that unlocking the value of data would drive immense value for our customers,” says Dhiren Bhatia, founder and president of Viewics. “With Roche’s expertise and strong alignment within our teams, we are excited to embark on this next phase of Viewics’ journey and jointly deliver on this mission.”
“Viewics strives to provide unprecedented access to disparate healthcare data to surface actionable insights and empower data-driven decisionmaking,” says Keith Laughman, CEO of Viewics. “The Viewics platform generates insights that can inform real-time decisions about costs, laboratory performance, and many other areas affecting today’s modern healthcare organizations. We are looking forward to working with our Roche colleagues in helping to support the lab’s critical role in healthcare delivery.”
The Viewics solution offers automated data extraction, cleansing, and augmentation architecture, and is designed to resolve many of the typical problems that laboratory IT staff encounter when using generic business intelligence solutions, traditional data warehousing, or extraction methodologies.
For further information, visit Roche.